The SIK2 Inhibitor GRN-300 Enhances PARP Inhibitor Sensitivity and Cytotoxic T-Cell Function in Ovarian Cancer

$177,085P50FY2025CANIH

University Of Tx Md Anderson Can Ctr, Houston TX

Investigators

Robert C Bastcontact

Linked publications, trials & patents

Paper 39622255 Paper 39582325 Paper 39582234 Paper 39468742 Paper 39275895 Paper 39253988 Paper 39114948 Paper 39053568 Paper 38582949 Paper 38565883 Paper 38287471 Paper 38250760 Paper 38191019 Paper 38009662

View original record on NIH RePORTER →